PHARMExcel supports successful first-in-human trial of AI-designed universal coronavirus vaccine
PHARMExcel Supports Successful First-in-Human Trial of AI-Designed Universal Coronavirus Vaccine.
PHARMExcel Supports Successful First-in-Human Trial of AI-Designed Universal Coronavirus Vaccine.
Recognition for collaboration with the University of Southampton highlights growing impact of Contract Research Organisation (CRO)–academic partnerships in medical device research.
PHARMExcel celebrates recognition for most impactful CRO-industry collaboration award – Rare disease Bardet Biedl Syndrome study in partnership with Axovia Therapeutics.
There’s a new model driving vaccine innovation. Find out how PHARMExcel delivers clinical trials in a new collaborative ecosystem.
COVBoost Vaccine Trial – Relevant Lessons for Today
Discover expert guidance on UK, EU & US medical device regulatory support. Learn how PHARMExcel helps start-ups run clinical trials and reach market faster.
PHARMExcel presents vaccine study learnings at World Vaccine Congress 2025
PHARMExcel is delighted to be nominated for Best Specialist CRO by the prestigious pharma Industry SCRIP Award 2025 for the second year running.